Axcella Health

Axcella is a clinical-stage biotechnology company creating therapies to treat complex diseases using compositions of endogenous metabolic modulators.

neon closed sign in window
Biotech

Flagship-founded Axcella folds

After a 12-year run, the Flagship-founded Axcella is shuttering.
Gabrielle Masson Dec 5, 2023 10:36am
graphic of someone pulling a large coronavirus representative of the virus being burdensome

'We beg you': Biotechs plead for help with long COVID research

Feb 22, 2023 11:20am
climbing rock climber

JPM23: After rock climbing in biotech, Novartis' CMO is back

Jan 12, 2023 6:00am
Liver doctor holding liver

With cash dwindling, Axcella shares look at blinded NASH data

Sep 29, 2022 7:30am
Long COVID

Axcella misses main goal in long COVID, plots path to market

Aug 2, 2022 6:00am
Long COVID

Axcella CEO hits Washington to drum up support for long COVID

Jun 21, 2022 5:00am